Provided by Tiger Trade Technology Pte. Ltd.

Cellectar Biosciences

2.44
+0.01000.41%
Volume:5K
Turnover:10.96K
Market Cap:23.06M
PE:-1.10
High:2.44
Open:2.39
Low:2.39
Close:2.43
52wk High:6.52
52wk Low:2.20
Shares:9.45M
Float Shares:9.01M
Volume Ratio:7.56
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2100
EPS(LYR):-8.3544
ROE:-119.57%
ROA:-58.44%
PB:0.77
PE(LYR):-0.29

Loading ...

Aug 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2020

Major Issues Report

8-K - Current report
Aug 04, 2020

Major Issues Report

8-K - Current report
Jul 21, 2020

Major Issues Report

8-K - Current report
Jul 13, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 10, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jul 01, 2020

Major Issues Report

8-K - Current report
Jun 25, 2020

Major Issues Report

8-K - Current report
Jun 12, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 12, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 11, 2020

Major Issues Report

8-K - Current report
Jun 10, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 05, 2020

Major Issues Report

8-K - Current report
Jun 03, 2020

Major Issues Report

8-K - Current report
Jun 01, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jun 01, 2020

Major Issues Report

8-K - Current report
May 26, 2020

Major Issues Report

8-K - Current report
May 20, 2020

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 20, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 14, 2020

Major Issues Report

8-K - Current report